PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BBWI vs. MRNA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


BBWIMRNA
YTD Return-26.35%-60.01%
1Y Return-1.58%-47.91%
3Y Return (Ann)-23.77%-44.78%
5Y Return (Ann)24.14%15.51%
Sharpe Ratio0.04-0.79
Sortino Ratio0.35-1.06
Omega Ratio1.040.87
Calmar Ratio0.02-0.50
Martin Ratio0.06-1.32
Ulcer Index24.33%35.11%
Daily Std Dev42.03%58.52%
Max Drawdown-87.49%-91.79%
Current Drawdown-57.70%-91.79%

Fundamentals


BBWIMRNA
Market Cap$6.92B$16.73B
EPS$4.12-$5.81
PEG Ratio0.950.00
Total Revenue (TTM)$5.82B$5.08B
Gross Profit (TTM)$2.57B$3.35B
EBITDA (TTM)$1.21B-$2.41B

Correlation

-0.50.00.51.00.2

The correlation between BBWI and MRNA is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

BBWI vs. MRNA - Performance Comparison

In the year-to-date period, BBWI achieves a -26.35% return, which is significantly higher than MRNA's -60.01% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%JuneJulyAugustSeptemberOctoberNovember
-35.34%
-70.03%
BBWI
MRNA

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BBWI vs. MRNA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bath & Body Works, Inc. (BBWI) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BBWI
Sharpe ratio
The chart of Sharpe ratio for BBWI, currently valued at 0.04, compared to the broader market-4.00-2.000.002.004.000.04
Sortino ratio
The chart of Sortino ratio for BBWI, currently valued at 0.35, compared to the broader market-4.00-2.000.002.004.006.000.35
Omega ratio
The chart of Omega ratio for BBWI, currently valued at 1.04, compared to the broader market0.501.001.502.001.04
Calmar ratio
The chart of Calmar ratio for BBWI, currently valued at 0.02, compared to the broader market0.002.004.006.000.02
Martin ratio
The chart of Martin ratio for BBWI, currently valued at 0.06, compared to the broader market0.0010.0020.0030.000.06
MRNA
Sharpe ratio
The chart of Sharpe ratio for MRNA, currently valued at -0.79, compared to the broader market-4.00-2.000.002.004.00-0.79
Sortino ratio
The chart of Sortino ratio for MRNA, currently valued at -1.06, compared to the broader market-4.00-2.000.002.004.006.00-1.06
Omega ratio
The chart of Omega ratio for MRNA, currently valued at 0.87, compared to the broader market0.501.001.502.000.87
Calmar ratio
The chart of Calmar ratio for MRNA, currently valued at -0.50, compared to the broader market0.002.004.006.00-0.50
Martin ratio
The chart of Martin ratio for MRNA, currently valued at -1.32, compared to the broader market0.0010.0020.0030.00-1.32

BBWI vs. MRNA - Sharpe Ratio Comparison

The current BBWI Sharpe Ratio is 0.04, which is higher than the MRNA Sharpe Ratio of -0.79. The chart below compares the historical Sharpe Ratios of BBWI and MRNA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00JuneJulyAugustSeptemberOctoberNovember
0.04
-0.79
BBWI
MRNA

Dividends

BBWI vs. MRNA - Dividend Comparison

BBWI's dividend yield for the trailing twelve months is around 2.55%, while MRNA has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
BBWI
Bath & Body Works, Inc.
2.55%1.85%1.90%0.60%1.00%8.20%11.57%4.93%8.27%5.17%3.37%2.40%
MRNA
Moderna, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

BBWI vs. MRNA - Drawdown Comparison

The maximum BBWI drawdown since its inception was -87.49%, roughly equal to the maximum MRNA drawdown of -91.79%. Use the drawdown chart below to compare losses from any high point for BBWI and MRNA. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%JuneJulyAugustSeptemberOctoberNovember
-57.70%
-91.79%
BBWI
MRNA

Volatility

BBWI vs. MRNA - Volatility Comparison

Bath & Body Works, Inc. (BBWI) and Moderna, Inc. (MRNA) have volatilities of 13.47% and 13.54%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
13.47%
13.54%
BBWI
MRNA

Financials

BBWI vs. MRNA - Financials Comparison

This section allows you to compare key financial metrics between Bath & Body Works, Inc. and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items